Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 8/20 | 0.51 |
| ▸ | DPP9 | Q86TI2 | 6/20 | 0.51 |
| ▸ | DPP8 | Q6V1X1 | 5/20 | 0.51 |
| ▸ | DPP4 | P27487 | 3/20 | 0.51 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.46 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.46 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.46 |
| ▸ | SLC15A1 | P46059 | 1/20 | 0.44 |
| ▸ | GSR | P00390 | 1/20 | 0.44 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.42 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.42 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.42 |
| ▸ | RRM1 | P23921 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | METAP1 | P53582 | 1/20 | 0.40 |
| ▸ | TLR2 | O60603 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1484685 | 0.94 | GNAI3 (0.53) | DPP7DPP9DPP8DPP4GNAI3 | |
| SCHEMBL5497695 | 0.92 | DPP7 (0.50) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL21114423 | 0.92 | DPP7 (0.50) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL6445484 | 0.92 | DPP7 (0.50) | DPP7DPP9DPP8DPP4SLC15A1 | |
| SCHEMBL997560 | 0.90 | GSR (0.52) | DPP7DPP9DPP8DPP4GNAI3 | |
| SCHEMBL29075853 | 0.90 | GSR (0.52) | DPP7DPP9DPP8DPP4GNAI3 | |
| SCHEMBL1537223 | 0.90 | GSR (0.52) | DPP7DPP9DPP8DPP4GNAI3 | |
| SCHEMBL28782508 | 0.89 | GSR (0.44) | DPP7DPP9DPP8DPP4GNAI3 | |
| SCHEMBL680614 | 0.86 | GSR (0.59) | DPP7DPP9DPP8DPP4GNAI3 | |
| SCHEMBL2029834 | 0.85 | GSR (0.44) | DPP7DPP9DPP8DPP4GNAI3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1590 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12037593-B2 | Methods and means for modifying the alkaloid content of plants | BRITISH AMERICAN TOBACCO (INVESTMENTS) LIMITED (GB) | 2024-07-16 | — | — | US | disclosed |
| EP-3500670-B1 | METHOD FOR SELECTING TARGET SEQUENCES FOR GUIDE RNA OF CRISPR SYSTEMS | BROAD INST INC (US) | 2024-07-10 | — | — | EP | disclosed |
| EP-3500671-B1 | METHOD OF SELECTING TARGET SEQUENCES FOR THE DESIGN OF GUIDE RNAS | BROAD INST INC (US) | 2024-07-10 | — | — | EP | disclosed |
| CN-113355307-B | Proteins | 国际N&H丹麦有限公司 | 2024-07-05 | — | — | CN | disclosed |
| WO-2024145191-A2 | METHODS FOR PRODUCING PLANT BASED FOOD ALTERNATIVES | INTERNATIONAL N&H DENMARK APS (DK) | 2024-07-04 | — | — | WO | disclosed |
| US-12023391-B2 | Alpha(v)beta(6) integrin-binding peptides and methods of use thereof | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2024-07-02 | — | — | US | disclosed |
| US-20240209359-A1 | METHODS, SYSTEMS, AND APPARATUS FOR IDENTIFYING TARGET SEQUENCES FOR CAS ENZYMES OR CRISPR-CAS SYSTEMS FOR TARGET SEQUENCES AND CONVEYING RESULTS THEREOF | THE BROAD INSTITUTE, INC. (US) | 2024-06-27 | — | — | US | disclosed |
| US-12018275-B2 | Delivery and use of the CRISPR-CAS systems, vectors and compositions for hepatic targeting and therapy | THE BROAD INSTITUTE, INC. (US) | 2024-06-25 | — | — | US | disclosed |
| US-20240191223-A1 | TYPE VI CRISPR ORTHOLOGS AND SYSTEMS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2024-06-13 | — | — | US | disclosed |
| US-20240180172-A1 | AMYLASE POLYPEPTIDES WITH IMPROVED PROPERTIES | DUPONT NUTRITION BIOSCI APS (DK) | 2024-06-06 | — | — | US | disclosed |
| WO-2001077380-A2 | METHOD FOR PREDICTING PREDISPOSITION TO A DISEASE ASSOCIATED WITH MUTATIONS IN A RPGR GENE | MEDICAL RESEARCH COUNCIL (GB) | 2001-10-18 | — | — | WO | disclosed |
| EP-1135410-A2 | ANTENNAPEDIA HOMEODOMAIN HELIX 3 DERIVED TRANSLOCATION VECTORS | Cyclacel Limited (GB) | 2001-09-26 | — | — | EP | disclosed |
| EP-1118858-A2 | Assay method | Pfizer Limited (GB) | 2001-07-25 | — | — | EP | disclosed |
| EP-1108360-A1 | Method of improving dough and bread quality | DANISCO A/S (DK) | 2001-06-20 | — | — | EP | disclosed |
| WO-2001039602-A1 | METHOD OF IMPROVING DOUGH AND BREAD QUALITY | DANISCO A/S (DK) | 2001-06-07 | — | — | WO | disclosed |
| EP-1097718-A1 | NPY antagonists for the treatment of female sexual dysfunction | Pfizer Limited (GB) | 2001-05-09 | — | — | EP | disclosed |
| EP-1097719-A1 | NEP inhibitors for the treatment of female sexual dysfunction | Pfizer Limited (GB) | 2001-05-09 | — | — | EP | disclosed |
| EP-1097706-A1 | Phosphodiesterase inhibitors for the treatment of female sexual dysfunction | Pfizer Limited (GB) | 2001-05-09 | — | — | EP | disclosed |
| EP-1097707-A1 | Treatment of female sexual dysfunction | Pfizer Limited (GB) | 2001-05-09 | — | — | EP | disclosed |
| WO-2000029427-A2 | ANTENNAPEDIA HOMEODOMAIN HELIX 3 DERIVED TRANSLOCATION VECTORS | CYCLACEL LIMITED (GB) | 2000-05-25 | — | — | WO | disclosed |